Home PMV Pharmaceuticals

PMV Pharmaceuticals

In operation
IPO
Small Molecule Drug Developer for Cancer Treatment

Basic Information

PMV Pharmaceuticals is dedicated to the discovery and development of small molecule drugs targeting p53 for cancer treatment. PMV Pharmaceuticals is developing first-class p53 modulators for cancer therapy. PMV Pharma brings together leaders in the field to leverage over thirty years of p53 biology expertise, combining unique biological insights with a focus on drug development.
PMV Pharmaceuticals, Inc.
NewJersey,United States of America
15~50 people
January 01, 2013
info@pmvpharma.com